Metraipolis › archive › dc_dda2300eaa50

A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-κB inhibitors active against eumycetoma — Europe PMC PMID:41016854

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41016854
DOI
10.1093/jac/dkaf369
License (as archived)
solo-consultazione
Archived
2026-11-08T03:13:31.088Z
SHA-256 of the archived text
02befaeb13e8917199632a49d13d3141607157021519f4d6b493eebbf579f2a2
Stable URL of this page
https://metraipolis.com/documento/dc_dda2300eaa50

How to cite

A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-κB inhibitors active against eumycetoma — Europe PMC PMID:41016854 — Europe PMC (en), https://europepmc.org/article/MED/41016854 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dda2300eaa50 (Metraipolis archive dc_dda2300eaa50, sha256 02befaeb13e8917199632a49d13d3141607157021519f4d6b493eebbf579f2a2)
BibTeX
@misc{dcdda2300eaa50,
  title = {A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-κB inhibitors active against eumycetoma — Europe PMC PMID:41016854},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41016854},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dda2300eaa50; sha256 02befaeb13e8917199632a49d13d3141607157021519f4d6b493eebbf579f2a2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41016854. Agents can read the archived copy with the MCP tool read_document.